UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060911
Receipt number R000069694
Scientific Title EMDR Resource Development and Installation for Individuals with Disturbances in Self-Organization Related to Adverse Childhood Experiences: A Pilot Single-arm Trial
Date of disclosure of the study information 2026/03/19
Last modified on 2026/03/19 16:33:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Pilot Study of an EMDR-Based Positive Imagery Exercise for People with Psychological Difficulties Related to Childhood Adversity

Acronym

A Pilot Study of an EMDR-Based Positive Imagery Exercise

Scientific Title

EMDR Resource Development and Installation for Individuals with Disturbances in Self-Organization Related to Adverse Childhood Experiences: A Pilot Single-arm Trial

Scientific Title:Acronym

EMDR-RDI for Disturbances in Self-Organization: Pilot Study

Region

Japan


Condition

Condition

Disturbances in Self-Organization Related to Adverse Childhood Experiences

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the feasibility, acceptability, and safety of EMDR Resource Development and Installation (RDI) for individuals with Disturbances in Self-Organization (DSO) related to Adverse Childhood Experiences (ACEs).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

To assess feasibility, the following indicators will be used:
- Recruitment rate (number of participants enrolled / target sample size)
- Dropout rate (number of dropouts / number of participants), including reasons for dropout
- Protocol adherence rate
- Average duration per session (minutes)
Recruitment rate, dropout rate, and protocol adherence rate will be calculated and reported as proportions. Reasons for dropout will be categorized, with specific details provided if necessary. The average duration per session will be reported as mean and standard deviation.

Key secondary outcomes

1. Acceptability
The following measures will be used to assess acceptability:
- Client Satisfaction Questionnaire (CSQ-8-J, Japanese version): assessed once after completion of all intervention sessions
- Open-ended questionnaire on seven concepts of acceptability: assessed once on a later day following the completion of all intervention sessions using Microsoft Forms
The results of the CSQ-8-J will be reported using descriptive statistics, including the mean, standard deviation, median, and range. Responses to the open-ended questionnaire will be analyzed qualitatively using thematic analysis based on Braun & Clarke (2006).

2. Safety
The following measures will be used to assess safety:
- Brief questionnaires monitoring suicidal thoughts, self-harm behaviors, and symptom worsening: assessed at the beginning of each intervention session
The trial will be discontinued for affected participants, and, if necessary, emergency measures will be taken to ensure their safety. The number of participants who discontinue and the reasons for discontinuation will be reported.

3. Exploratory symptom changes
The following measures will be used to assess changes in symptoms:
- International Trauma Questionnaire (ITQ-J, Japanese version)
- Posttraumatic Diagnostic Scale for DSM-IV (PDS-IV-J, Japanese version)
These measures will be assessed at baseline and 1 month after completion of the final intervention session.
For statistical analyses, a paired t-test will be used when the assumption of normality is met, and the Wilcoxon signed-rank test will be used when the assumption is not met. The significance level will be set at 5%. In addition, effect sizes and the Reliable Change Index will be calculated and reported. Statistical analyses will be conducted using R version 4.5.2 (R Core Team, 2026).
This analysis is not intended to evaluate efficacy, but rather to explore the magnitude and direction of symptom changes to inform the design of future studies.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Resource Development and Installation (RDI) in Eye Movement Desensitization and Reprocessing (EMDR)

RDI is a stabilization technique in EMDR for complex PTSD, based on the protocol by Korn and Leeds (2002). The intervention consists of three weekly sessions, each lasting 60 minutes.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Aged 18 to 65 years at the time of informed consent
2) Native Japanese speakers
3) Experienced Adverse Childhood Experiences (ACEs) before the age of 18, as assessed using the ACE scale for the Japanese context (ACE-J)
4) Meet the Disturbances in Self-Organization (DSO) criteria for complex PTSD, as assessed using the Japanese version of the International Trauma Questionnaire (ITQ-J)

Key exclusion criteria

1) Current substance abuse
2) Current alcohol-related problems
3) Diagnosis of schizophrenia
4) Diagnosis of bipolar disorder
5) Cognitive impairment that significantly interferes with daily functioning
6) Acute suicidality within the past year, requiring hospitalization or referral to an emergency department
7) Specific preparation or planning for suicide within the past year
8) Received EMDR therapy within the past 6 months
9) Currently receiving trauma-focused psychotherapy

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Chihoko
Middle name
Last name Unno

Organization

Hyogo University of Teacher Education

Division name

Graduate School of Education

Zip code

673-1494

Address

942-1 Shimokume, Kato-city, Hyogo, 673-1494, Japan

TEL

0795-44-2068

Email

cunnotom@hyogo-u.ac.jp


Public contact

Name of contact person

1st name Shunsuke
Middle name
Last name Sato

Organization

Hyogo University of Teacher Education

Division name

Joint Graduate School (Ph.D. Program) in Science of School Education

Zip code

673-1494

Address

942-1 Shimokume, Kato-city, Hyogo, 673-1494, Japan

TEL

0795-44-2068

Homepage URL


Email

d24202h@hyogo-u.ac.jp


Sponsor or person

Institute

Hyogo University of Teacher Education

Institute

Department

Personal name

Chihoko Unno


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Counseling Room Seqoia
Arata Clinic of Psychosomatic Medicine

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee of Hyogo University of Teacher Education

Address

942-1 Shimokume, Kato-city, Hyogo, 673-1494, Japan

Tel

N/A

Email

office-kenkyu-t@ml.hyogo-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 03 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 02 Month 26 Day

Date of IRB

2026 Year 03 Month 11 Day

Anticipated trial start date

2026 Year 04 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 03 Month 12 Day

Last modified on

2026 Year 03 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069694